The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Open accessAbstract
Glioblastoma (GBM) is a highly lethal brain tumour presenting as one of two subtypes with distinct clinical histories and molecular profiles. The primary GBM subtype presents acutely as a high-grade disease that typically harbours mutations in EGFR, PTEN and INK4A/ARF (also known as CDKN2A), and the secondary GBM subtype evolves from the slow progression of a low-grade disease that classically possesses PDGF and TP53 events. Here we show that concomitant central nervous system (CNS)-specific deletion of p53 and Pten in the mouse CNS generates a penetrant acute-onset high-grade malignant glioma phenotype with notable clinical, pathological and molecular resemblance to primary GBM in humans. This genetic observation prompted TP53 and PTEN mutational analysis in human primary GBM, demonstrating unexpectedly frequent inactivating mutations of TP53 as well as the expected PTEN mutations. Integrated transcriptomic profiling, in silico promoter analysis and functional studies of murine neural stem cells (NSCs) established that dual, but not singular, inactivation of p53 and Pten promotes an undifferentiated state with high renewal potential and drives increased Myc protein levels and its associated signature. Functional studies validated increased Myc activity as a potent contributor to the impaired differentiation and enhanced renewal of NSCs doubly null for p53 and Pten (p53(-/-) Pten(-/-)) as well as tumour neurospheres (TNSs) derived from this model. Myc also serves to maintain robust tumorigenic potential of p53(-/-) Pten(-/-) TNSs. These murine modelling studies, together with confirmatory transcriptomic/promoter studies in human primary GBM, validate a pathogenetic role of a common tumour suppressor mutation profile in human primary GBM and establish Myc as an important target for cooperative actions of p53 and Pten in the regulation of normal and malignant stem/progenitor cell differentiation, self-renewal and tumorigenic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although TP53 mutations are oncogenic in GBM, other genes, such as PTEN must also be mutated to drive GBM progression [28].”
From The p53 Pathway in Glioblastoma (2018) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Similarly, the chronic cellular damage that leads to liver cirrhosis results in shortened telomeres, anaphase bridges and a dramatically increased risk of liver cancer (131-134).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Self-citationErratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,435
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Self-citationClarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Self-citationMultiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint
Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 759
Costa, B., Fletcher, M. N. C., Boskovic, P., Ivanova, E. L., Eisemann, T., Lohr, S., Bunse, L., Löwer, M., Burchard, S., Korshunov, A., et al. (2021) · Cancers · doi:10.3390/cancers13020230 · Cited by 22
Pten-mediated Gsk3β modulates the naïve pluripotency maintenance in embryonic stem cells
Wang, W., Lü, G., Su, X., Tang, C., Li, H., Xiong, Z., Leung, C., Wong, M. S., Liu, H., Ma, J., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2271-0 · Cited by 21
Cancer cell-selective aggregation-induced emission probe for long-term plasma membrane imaging
Wu, M., Leung, J., Kam, C., Situ, B., Wu, Z., Chou, T. Y., Feng, S., & Chen, S. (2022) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2021.100735 · Cited by 21
Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression
Ogunleye, A. O., Nimmakayala, R. K., Batra, S. K., & Ponnusamy, M. P. (2023) · Stem Cells · doi:10.1093/stmcls/sxad017 · Cited by 21
HOXDeRNA activates a cancerous transcription program and super enhancers via genome-wide binding
Deforzh, E., Kharel, P., Zhang, Y., Karelin, A., Khayari, A. E., Ivanov, P. V., & Krichevsky, A. M. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.09.018 · Cited by 21
Qualitative Network Modeling of the Myc-p53 Control System of Cell Proliferation and Differentiation
Aguda, B. D., Kim, Y., Kim, H. S., Friedman, A., & Fine, H. A. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.09.052 · Cited by 21
Zhu, H., Wang, H., Huang, Q., Liu, Q., Guo, Y., Lu, J., Li, X., Xue, C., & Han, Q. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00187 · Cited by 22
Knauss, J. L., Bian, S., & Sun, T. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00163 · Cited by 21
Inactivation of the ATMIN/ATM pathway protects against glioblastoma formation
Blake, S. M., Stricker, S. H., Halavach, H., Poetsch, A. R., Cresswell, G. D., Kelly, G. P., Kanu, N., Marino, S., Luscombe, N. M., Pollard, S. M., et al. (2016) · eLife · doi:10.7554/elife.08711 · Cited by 21
Bakhshinyan, D., Savage, N. J., Salim, S. K., Venugopal, C., & Singh, S. K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.603738 · Cited by 21
Ostrakhovitch, E. A., & Semenikhin, O. A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.061 · Cited by 21
Signals that regulate the oncogenic fate of neural stem cells and progenitors
Swartling, F. J., Bolin, S., Phillips, J. J., & Persson, A. I. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.01.027 · Cited by 22
The role of glioma stem cells in glioma tumorigenesis
Yin, C. (2014) · Frontiers in bioscience · doi:10.2741/4249 · Cited by 20
Cancer Stem Cells in Pediatric Brain Tumors
Lasky, J. L., Choe, M. C., & Nakano, I. (2009) · Current Stem Cell Research & Therapy · doi:10.2174/157488809789649278 · Cited by 20
Loss of Tsc1 accelerates malignant gliomagenesis when combined with oncogenic signals
Yamada, D., Hoshii, T., Tanaka, S., Hegazy, A. M., Kobayashi, M., Tadokoro, Y., Ohta, K., Ueno, M., Ali, M. A., & Hirao, A. (2013) · The Journal of Biochemistry · doi:10.1093/jb/mvt112 · Cited by 21
Context matters – Daxx and Atrx are not robust tumor suppressors in the murine endocrine pancreas
Sun, C., Estrella, J. S., Whitley, E. M., Chau, G. P., Lozano, G., & Wasylishen, A. R. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049552 · Cited by 21
Qiao, D., Meyer, K. K., & Friedl, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00238-13 · Cited by 19
RetractedWhat underlies the diversity of brain tumors?
Swartling, F. J., Hede, S., & Weiss, W. A. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9407-3 · Cited by 19
Markert, J. M., Whisenhunt, T. R., Rajneesh, K., & Hackney, J. R. (2015) · Oncolytic Virotherapy · doi:10.2147/ov.s62461 · Cited by 19
Progenitor-like Traits Contribute to Patient Survival and Prognosis in Oligodendroglial Tumors
Ng, F. S.-L., Toh, T. B., Ting, E. H.-L., Koh, G. R. H., Sandanaraj, E., Phong, M., Wong, S. S., Leong, S. H., Kon, O. L., Tucker‐Kellogg, G., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3064 · Cited by 19
Differentiation of Pancreatic Acinar Cells to Hepatocytes Requires an Intermediate Cell Type
Wu, S., Hsieh, C., Wu, R., Susanto, J., Liu, T., Shen, C., Chen, Y., Su, C., Chang, F., Chang, H., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.011 · Cited by 19
WIP-YAP/TAZ as A New Pro-Oncogenic Pathway in Glioma
Rivas-Muñoz, S., Antón, I. M., & Wandosell, F. G. (2018) · Cancers · doi:10.3390/cancers10060191 · Cited by 19
Zhang, Z., Zheng, X., Liu, Y., Luan, Y., Wang, L., Zhao, L., Zhang, J., Tian, Y., Lü, H., Chen, X., et al. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14984 · Cited by 19
The PTEN and Myotubularin Phosphoinositide 3-Phosphatases: Linking Lipid Signalling to Human Disease
Davies, E. M., Sheffield, D. A., Tibarewal, P., Fedele, C. G., Mitchell, C. A., & Leslie, N. R. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-3012-0_8 · Cited by 19
Xie, Z. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0079-5 · Cited by 19
TRIAD1 inhibits MDM2‐mediated p53 ubiquitination and degradation
Bae, S., Jung, J. H., Kim, K., An, I., Kim, S., Lee, J. H., Park, I., Jin, Y.-W., Lee, S., & An, S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.022 · Cited by 19
Stem cells and lung cancer: future therapeutic targets?
Alison, M. R., Brenne, A. C. L., & Islam, S. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903103803 · Cited by 19
Boskovic, P., Wilke, N., Man, K.-H., Lichter, P., Francois, L., & Radlwimmer, B. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad190 · Cited by 18
Mouse Models of Experimental Glioblastoma
Jin, F., Jin‐Lee, H. J., & Johnson, A. J. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.gliomas.2021.chapter2 · Cited by 18
Stem Cells in Brain Tumor Development
Llaguno, S. R. A., Chen, Y., McKay, R. M., & Parada, L. F. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00002-4 · Cited by 18
RUNX 3 is down‐regulated in glioma by Myc‐regulated miR‐4295
Li, X., Zheng, J., Diao, H., & Liu, Y. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12736 · Cited by 18
Liang, H., Wang, Q., Wang, D., Zheng, H., Kalvakolanu, D. V., Lu, H., Wen, N., Chen, X., Xu, L., Ren, J., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114118 · Cited by 18
Self-citationRapamycin induces differentiation of glioma stem/progenitor cells by activating autophagy
Zhuang, W., Long, L., Ji, W.-J., & Liang, Z. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10234 · Cited by 18
Zhang, L., Laaniste, L., Jiang, Y., Alafuzoff, I. I., Uhrbom, L., & Dimberg, A. (2016) · Oncotarget · doi:10.18632/oncotarget.12983 · Cited by 18
Glioblastoma stem cells induce quiescence in surrounding neural stem cells via Notch signalingPreprint
Lawlor, K., Marqués‐Torrejón, M. Á., Dharmalingham, G., El-Azhar, Y., Schneider, M. D., Pollard, S. M., & Rodríguez, T. A. (2020) · Genes & Development · doi:10.1101/gad.336917.120 · Cited by 18
Kong, J., Mei, Z., Zhang, Y., Xu, L.-Z., Zhang, J., & Wang, Y. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216265 · Cited by 17
Self-citationUnravelling the mosaic: Epigenetic diversity in glioblastoma
Lucchini, S., Constantinou, M., & Marino, S. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13706 · Cited by 17
The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma
Karsy, M. J., Albert, L., Murali, R., & Jhanwar‐Uniyal, M. (2014) · Tumor Biology · doi:10.1007/s13277-013-1601-6 · Cited by 17
Revisit the Candidacy of Brain Cell Types as the Cell(s) of Origin for Human High-Grade Glioma
Shao, F., & Liu, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00048 · Cited by 17
Human tripartite motif protein 52 is required for cell context-dependent proliferation
Benke, S., Agerer, B., Haas, L., Stöger, M., Lercher, A., Gabler, L., Kiss, I., Scinicariello, S., Berger, W., Bergthaler, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24422 · Cited by 17
p53 Mutant p53N236S Induces Neural Tube Defects in Female Embryos
Zhao, J., Tian, Y., Zhang, H., Qu, L., Chen, Y., Liu, Q., Luo, Y., & Wu, X. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.31451 · Cited by 17
Yang, X., Zhang, C., Tie, H., Luo, J., Wang, Y., & Wu, Q. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29540 · Cited by 17
Self-citationFeasibility of Targeting Glioblastoma Stem Cells: From Concept to Clinical Trials
Tarasov, V. V., Svistunov, A. А., Chubarev, V. N., Zatsepilova, T. A., Preferanskaya, N., Степанова, О. И., Sokolov, A. V., Dostdar, S. A., Minyaeva, N. N., Неганова, М. Е., et al. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191112140939 · Cited by 17
Novel ablation methods for treatment of gliomas
Partridge, B. R., Rossmeisl, J. H., Kaloss, A. M., Basso, E. K. G., & Theus, M. H. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108630 · Cited by 17
β1,4-Galactosyltransferase V regulates self-renewal of glioma-initiating cell
Wei, Y., Zhou, F., Ge, Y., Chen, H., Cui, C., Li, Q., Liu, D., Yang, Z., Wu, G., Sun, S., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.110 · Cited by 17
The top cited articles on glioma stem cells in Web of Science.
Yi, F., Ma, J., Ni, W., Chang, R., Liu, W., Han, X., Pan, D., Liu, X., & Jian-wu, Q. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.15.011 · Cited by 17
Cut the fat: targeting cholesterol and lipid metabolism in glioblastoma
Zekanovic, S., Sing, P. A., Leenstra, S., & Lamfers, M. L. M. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07993-3 · Cited by 16
Functional network analysis of gene-phenotype connectivity associated with temozolomide
Shi, J. H., Dong, B., Zhou, P., Guan, W., & Peng, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.20848 · Cited by 16
Asymmetric cell division: Implications for glioma development and treatment
Lewis, K., & Petritsch, C. K. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0148-8 · Cited by 16
Tomé, M., Tchorz, J. S., Gassmann, M., & Bettler, B. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101390 · Cited by 16
Fan, Z., Liu, Y., Li, S., Liu, X., Jiang, T., Wang, Y., & Wang, L. (2020) · Aging · doi:10.18632/aging.103110 · Cited by 16
Self-citationPhon, B. W. S., Kamarudin, M. N. A., Bhuvanendran, S., & Radhakrishnan, A. K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112396 · Cited by 16
Chung, W.-M., Chang, W.-C., Chen, L., Lin, T., Chen, L.-C., Hung, Y.-C., & Ma, W. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.04.003 · Cited by 16
Islam, F., Gopalan, V., & Lam, A. K.-Y. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811785-9.00006-5 · Cited by 16
Gao, Y., Qiao, H., Lü, Z., & Hou, Y. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10445 · Cited by 16
Author Correction: Genetically engineered cerebral organoids model brain tumor formation
Bian, S., Repic, M., Guo, Z., Kavirayani, A. M., Burkard, T. R., Bagley, J. A., Krauditsch, C., & Knoblich, J. A. (2018) · Nature Methods · doi:10.1038/s41592-018-0118-8 · Cited by 19
Almazan, J. D., Turapov, T., Kircher, D. A., Stanley, K. A., Culver, K. M., Medellin, A. P., Field, M. N., Parkman, G. L., Colman, H., Coma, S., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101943 · Cited by 15
MiR-4310 induced by SP1 targets PTEN to promote glioma progression
Wu, Z., Luo, J. D., Huang, T., Yi, R., Ding, S., Xie, C., Xu, A., Zeng, Y., Wang, X., Song, Y., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01650-9 · Cited by 15
Regan, J. L., Schumacher, D., Staudte, S., Steffen, A., Lesche, R., Toedling, J., Jourdan, T., Haybaeck, J., Mumberg, D., Henderson, D. A., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102618 · Cited by 17
The Oncogenesis of Glial Cells in Diffuse Gliomas and Clinical Opportunities
Zhuang, Q., Yang, H., & Mao, Y. Q. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00953-3 · Cited by 16
Adesina, A. M., Veo, B. L., Courteau, G. R., Mehta, V. P., Wu, X., Pang, K., Liu, Z., Li, X., & Peters, L. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.08.003 · Cited by 15
P53 Promotes Retinoid Acid-induced Smooth Muscle Cell Differentiation by Targeting Myocardin
Tan, Z., Li, J., Zhang, X., Yang, X., Zhang, Z., Yin, K., & Huang, H. (2018) · Stem Cells and Development · doi:10.1089/scd.2017.0244 · Cited by 15
Genetic variants for head size share genes and pathways with cancer
Knol, M. J., Poot, R. A., Evans, T. E., Satizábal, C. L., Mishra, A., Sargurupremraj, M., der Auwera, S. V., Duperron, M., Jian, X., Hostettler, I. C., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101529 · Cited by 14
Li, F., Yang, K., Gao, X., Zhang, M., Gu, D., Wu, X., Lu, C., Wu, Q., Dixit, D., Gimple, R. C., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk9524 · Cited by 14
Chen, X., Wang, W., Zhang, J., Li, S., Zhao, Y., Tan, L., & Luo, A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.08.047 · Cited by 14
Xenopatients 2.0: Reprogramming the epigenetic landscapes of patient-derived cancer genomes
Menéndez, J. A., Alarcón, T., Corominas-Faja, B., Cuyàs, E., López‐Bonet, E., Martín, Á. G., & Vellón, L. (2014) · Cell Cycle · doi:10.4161/cc.27770 · Cited by 14
Cross Talk between Cellular Redox Status, Metabolism, and p53 in Neural Stem Cell Biology
Forsberg, K., & Giovanni, S. D. (2014) · The Neuroscientist · doi:10.1177/1073858413514634 · Cited by 14
Wip1 over‐expression correlated with TP53/p14ARF pathway disruption in human astrocytomas
Wang, P., Rao, J., Yang, H., Zhao, H., & Yang, L. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.22004 · Cited by 14
Basic Gene Expression Characteristics of Glioma Stem Cells and Human Glioblastoma
Sakamoto, D., Takagi, T., Fujita, M., Omura, S., Yoshida, Y., Iida, T., & Yoshimura, S. (2019) · Anticancer Research · doi:10.21873/anticanres.13153 · Cited by 14
Current understanding of gliomagenesis: from model to mechanism
Luo, J., Junaid, M., Hamid, N., Duan, J., Yang, X., & Pei, D. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.77287 · Cited by 15
Bone marrow osteoblast vulnerability to chemotherapy
Gencheva, M., Hare, I., Kurian, S., Fortney, J. E., Piktel, D., Wysolmerski, R. B., & Gibson, L. F. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12109 · Cited by 14
p53 Pathway Alterations in Brain Tumors
Yin, S., & Meir, E. G. V. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_14 · Cited by 15
The role of octamer binding transcription factors in glioblastoma multiforme
Rooj, A. K., Bronisz, A., & Godlewski, J. A. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.003 · Cited by 15
Astrocytes Can Adopt Endothelial Cell Fates in a p53-Dependent Manner
Brumm, A. J., Nuñez, S., Doroudchi, M. M., Kawaguchi, R., Duan, J., Pellegrini, M. A., Lam, L., Carmichael, S. T., Deb, A., & Hinman, J. D. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9974-3 · Cited by 14
Merve, A., Zhang, X., Pomella, N., Acquati, S., Hoeck, J. D., Dumas, A., Rosser, G., Li, Y., Jeyapalan, J. N., Vicenzi, S., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0739-x · Cited by 14
Gaps and Doubts in Search to Recognize Glioblastoma Cellular Origin and Tumor Initiating Cells
Włodarczyk, A., Grot, D., Stoczyńska-Fidelus, E., & Rieske, P. (2020) · Journal of Oncology · doi:10.1155/2020/6783627 · Cited by 14
Mulkearns-Hubert, E. E., Hajdari, N., Hong, E. S., Jacobs, A. P., Gaboriau, A., Giltner, S., Tannish, G., Kay, K. E., Wang, S. Z., LaViolette, P. S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116303 · Cited by 13
Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice
Qin, Y. H., Musket, A., Kou, J., Preiszner, J., Tschida, B. R., Qin, A., Land, C. A., Staal, B., Kang, L., Tanner, K. G., et al. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa067 · Cited by 13
Fujiwara, K., Ghosh, S., Liang, P., Morien, E., Soma, M., & Nagase, H. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22085 · Cited by 13
Benedykcinska, A., Ferreira, A., Lau, J., Broni, J., Richard-Loendt, A., Henriquez, N. V., & Brandner, S. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.022715 · Cited by 13
A simple and highly efficient method for multi‐allelic CRISPR‐Cas9 editing in primary cell cultures
Hoellerbauer, P., Kufeld, M., Arora, S., Wu, H., Feldman, H. M., & Paddison, P. J. (2020) · Cancer Reports · doi:10.1002/cnr2.1269 · Cited by 13
The SVZ and Its Relationship to Stem Cell Based Neuro-oncogenesis
Kusne, Y. N., & Sanai, N. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16537-0_2 · Cited by 13
Helpers of the cellular gatekeeper—miRNAs dance in P53 network
Shi, M., Liu, D., Shen, B., & Guo, N. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.12.001 · Cited by 13
In Silico Experiments in Scientific Papers on Molecular Biology
Moretti, S. (2011) · Science & Technology Studies · doi:10.23987/sts.55262 · Cited by 14
Kavaliauskaitė, D., Stakišaitis, D., Martinkutė, J., Šlekienė, L., Kazlauskas, A., Balnytė, I., Lesauskaitė, V., & Valančiūtė, A. (2017) · BioMed Research International · doi:10.1155/2017/6326053 · Cited by 13
“Super p53” Mice Display Retinal Astroglial Changes
Salazar, J. J., Gallego‐Pinazo, R., de Hoz, R., Pinazo-Duran, M. D., Rojas, B., Ramirez, A. I., Serrano, M., & Ramirez, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065446 · Cited by 12
Self-renewal mechanisms in neural cancer stem cells
Mantamadiotis, T. (2010) · Frontiers in bioscience · doi:10.2741/3708 · Cited by 12
Novel approaches to combat chemoresistance against glioblastomas
Towner, R. A., Zalles, M., Saunders, D., & Smith, N. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.38 · Cited by 12
Kim, D.-H., Kwon, W., Park, S., Kim, W., Park, J., Han, J. E., Cho, G., Yun, S., Han, S., Kim, M. O., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120170 · Cited by 12
Yang, B. Y., Wang, Y., Yang, C., Ouyang, W., Zhou, F., Zhou, Y., & Xie, C. (2012) · Ultrastructural Pathology · doi:10.3109/01913123.2012.708011 · Cited by 12
Self-citationDong, Y., Sui, L., Yamaguchi, F., Kamitori, K., Hirata, Y., Hossain, M. A., Suzuki, A., Holley, M. C., & Tokuda, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.024 · Cited by 12
Sun, Y., Tian, Y., Wang, G., Zhao, S., Han, B. R., Li, Y., & Jiang, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030235 · Cited by 12
Fonseca, M. B., Nunes, A. F., Morgado, A. L., Solá, S., & Rodrigues, C. M. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052417 · Cited by 12
High Expression of Pirh2 is Associated with Poor Prognosis in Glioma
Bao, Y., Wu, X., Yuan, D., Shi, W., & Shi, J. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0481-5 · Cited by 12
Proteomic Profiling of β-hCG-Induced Spheres in BRCA1 Defective Triple Negative Breast Cancer Cells
Sengodan, S. K., Rajan, A., Hemalatha, S. K., Nadhan, R., Jaleel, A., & Srinivas, P. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00562 · Cited by 12
Vinayak, M. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1539187 · Cited by 12
Advances in Glioblastoma Diagnosis: Integrating Genetics, Noninvasive Sampling, and Advanced Imaging
Gough, R., Treffy, R., Krucoff, M. O., & Desai, R. R. (2025) · Cancers · doi:10.3390/cancers17010124 · Cited by 12
Pekmez, M., Mete, Ş. B., Aksüt, Y., Öğütcü, İ., Baştürk, F. N., Gerçek, Y. C., & Şengelen, A. (2025) · Medical Oncology · doi:10.1007/s12032-025-02697-2 · Cited by 11
Immune Profiling of Syngeneic Murine and Patient GBMs for Effective Translation of Immunotherapies
Khalsa, J. K., & Shah, K. (2021) · Cells · doi:10.3390/cells10030491 · Cited by 11
Trivieri, N., Visioli, A., Mencarelli, G., Cariglia, M. G., Marongiu, L., Pracella, R., Giani, F., Soriano, A. A., Barile, C., Cajola, L., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02333-1 · Cited by 11
Metadata
- Authors
- Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., Stommel, J. M., Dunn, K. L., Wiedemeyer, R., You, M. J., Brennan, C., Wang, Y. A., Ligon, K. L., Wong, W. H., Chin, L., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Stanford University (US)
- Memorial Sloan Kettering Cancer Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- DePinho, Ronald A.
- ORCID
- Venue
- Nature
- Published
- 2008-10
- Volume
- 455
- Issue
- 7216
- Pages
- 1129-1133
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4051433
- OpenAlex
- W2109610561
- Cited by
- 767
- References
- 37
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 32 · 2023: 41 · 2022: 33 · 2021: 32 · 2020: 41 · 2019: 33 · 2018: 35 · 2017: 38 · 2016: 39 · 2015: 46 · 2014: 47 · 2013: 61 · 2012: 76
- FWCI
- 27.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- National Cancer Institute (R01 CA99041, R01CA099041, U01CA84313, 5P01CA95616, U01CA084313, P01CA095616)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- p53, PTEN, glioblastoma, neural stem cells, glioma stem cells, c-Myc, tumor suppressor inactivation, cell differentiation, cell renewal, TP53 mutation, PTEN mutation, gene expression profiling, promoter analysis, EGFR, neurofibromatosis type 1, RB1, ATM, APC
- MeSH terms
- Animals, Brain Neoplasms, Cell Differentiation, Gene Expression Regulation, Glioblastoma, Glioma, Humans, Immunohistochemistry, Neurons, Neoplastic Stem Cells, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-myc, Cell Proliferation, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review